| 2024-04-15 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 12,587 0.0128% | $133.36 | $1.68M | +3.78% | |
| 2024-03-14 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 69,521 0.0689% | $139.38 | $9.69M | -0.97% | |
| 2024-02-28 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 21,857 0.0219% | $134.69 | $2.94M | +2.3% | |
| 2024-02-13 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 1,098 0.0011% | $133.01 | $146,050 | +2.66% | |
| 2024-02-08 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 980 0.0009% | $134.19 | $131,509 | +1.66% | |
| 2024-02-06 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 1,280 0.0013% | $142.12 | $181,910 | -4.54% | |
| 2024-01-31 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 1,207 0.0012% | $140.78 | $169,927 | -1.96% | |
| 2023-08-21 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 1,600 0.0016% | $107.40 | $171,836 | +22.37% | |
| 2023-02-08 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 980 0.001% | $104.12 | $102,036 | +0.32% | |
| 2023-02-07 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 17,390 0.0177% | $102.41 | $1.78M | +0.86% | |
| 2023-02-06 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 1,280 0.0013% | $105.63 | $135,201 | -0.39% | |
| 2023-01-31 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 1,207 0.0012% | $109.95 | $132,710 | -5.7% | |
| 2023-01-06 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 400 0.0004% | $125.00 | $50,000 | -15.01% | |
| 2022-11-30 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 20,063 0.0206% | $125.90 | $2.53M | -17.67% | |
| 2022-11-10 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 100 0.0001% | $125.36 | $12,536 | -15.1% | |
| 2022-11-03 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 8,968 0.0094% | $125.02 | $1.12M | -15.71% | |
| 2022-10-17 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 4,960 0.0051% | $110.82 | $549,682 | -5.9% | |
| 2022-02-08 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 980 0.001% | $79.67 | $78,073 | +28.58% | |
| 2022-02-07 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 4,119 0.0043% | $80.78 | $332,748 | +26.82% | |
| 2021-08-16 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Commercial Officer | 5,628 0.0059% | $89.62 | $504,395 | +3.1% |